![[B] Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer.](/uploads/r/null/f/1/b/f1bd1623cdf41cc526be4879eec4c7d5a7795f046a66b1da207ebec998b32ce6/65f52ff2-086d-491e-a3d1-110b8ccf5f1c-_B__screencapture-bloomberg-press-releases-2020-11-16-myricx-pharma-2021-03-05-09_21_38_142.jpg)
Item
·
16/11/2020
Part of UoA 8
Press release for Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer
![[B] Bloomberg News Story on PsiQuantum](/uploads/r/null/a/e/4/ae452a7838e0de73c4f5d3d1aa2b3b7708aa2ec4092b9f9a6e494b9329b51e35/e8a6585c-abd8-47c1-88a4-9912ba754354-_B__bloomberg-news-articles_PsiQuantum_2020-12-01-09_38_06_142.jpg)